Back to Search
DAVID TUVESON, MD
MD
Medical Oncology Physician
NPI: 1720016223Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD421152L(PA)
Research & Publications (20)
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma.
PMID 16397237·Cancer Res·2006
7-preclinical
Ductal pancreatic cancer in humans and mice.
PMID 16869739·Cold Spring Harb Symp Quant Biol·2005
6-review
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.
PMID 15093544·Cancer Cell·2004
7-preclinical
BRAF as a potential therapeutic target in melanoma and other malignancies.
PMID 12957284·Cancer Cell·2003
6-review
Signal transduction pathways in sarcoma as targets for therapeutic intervention.
PMID 11429482·Curr Opin Oncol·2001
6-review
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications.
PMID 11526490·Oncogene·2001
8-other
An shRNA silencing a non-toxic transgene reduces nutrient consumption and increases production of adenoviral vectors in a novel packaging cell.
PMID 19117009·J Cell Physiol·2009
7-preclinical
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
PMID 19460966·Science·2009
7-preclinical
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.
PMID 18676756·Clin Cancer Res·2008
3-trial
K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses.
PMID 18374157·Methods Enzymol·2008
7-preclinical
Requirement for Rac1 in a K-ras induced lung cancer in the mouse.
PMID 17804720·Cancer Res·2007
7-preclinical
Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways.
PMID 17317860·Blood·2007
7-preclinical
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
PMID 17349581·Cancer Cell·2007
7-preclinical
Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis.
PMID 17369402·Genes Dev·2007
7-preclinical
The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.
PMID 17616662·Cancer Res·2007
7-preclinical
Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
PMID 17909062·Cancer Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 SPRUCE ST, 15 PENN TOWER
PHILADELPHIA, PA 19104 - Phone
- (215) 662-3914
Quick Facts
- NPI
- 1720016223
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile